Show simple item record

dc.creatorUnited Kingdom. Academy of Medical Sciencesen
dc.date.accessioned2011-07-12T18:26:49Zen
dc.date.available2011-07-12T18:26:49Zen
dc.date.created2003-07-19en
dc.date.issued2003-07-19en
dc.identifierhttp://www.acmedsci.ac.uk/p101puid60.htmlen
dc.identifier.bibliographicCitationLondon: Academy of Medical Sciences, 2003 July 19: 4 p. [Online]. Accessed: http://www.acmedsci.ac.uk/p101puid60.html [2009 July 22]en
dc.identifier.urihttp://hdl.handle.net/10822/524049en
dc.languageengen
dc.source261735en
dc.subjectPharmacogeneticsen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationGenetics, Molecular Biology and Microbiologyen
dc.titlePharmacogenetics: personalised safety and segmented efficacy. Summary of the lecture given by Dr Allen Roses on 31 March 2003, on the occasion of the launch of the Academy Forumen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885